XML 45 R36.htm IDEA: XBRL DOCUMENT
v3.25.3

Organization and Business (Details) store in Thousands, test in Millions |  | 3 Months Ended | 9 Months Ended
--- | --- | --- | ---
Sep. 22, 2025 entity | Sep. 30, 2025 USD ($) | Sep. 30, 2024 USD ($) | Sep. 30, 2025 USD ($) licensedCompound country test store inhibitor | Sep. 30, 2024 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Number of lab entities filed for Chapter 11 reorganization | entity | 3 |  |  |  |
Number of licensed compounds | licensedCompound |  |  |  | 2 |
Number of inhibitors | inhibitor |  |  |  | 2 |
General and administration |  | $ 4,635,000 | $ 6,573,000 | $ 13,351,000 | $ 20,805,000
DNA Expand |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Number of countries whole genome sequencing tests were obtained from | country |  |  |  | 130 |
Number of ancestry single nucleotide polymorphisms based tests equivalent | test |  |  |  | 150 |
Equivir |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
Number of FDM retail stores distributed in | store |  |  |  | 40 |
BE-Smart License Agreement |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |
General and administration |  |  |  | $ 0 | $ 200,000

X
- Definition Number Of Ancestry Single Nucleotide Polymorphisms Based Tests Equivalent + References No definition available. + Details
Name: | prph_NumberOfAncestrySingleNucleotidePolymorphismsBasedTestsEquivalent
Namespace Prefix: | prph_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number Of Countries Whole Genome Sequencing Tests Were Obtained From + References No definition available. + Details
Name: | prph_NumberOfCountriesWholeGenomeSequencingTestsWereObtainedFrom
Namespace Prefix: | prph_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number Of Food, Drug, And Mass Retail Stores Distributed In + References No definition available. + Details
Name: | prph_NumberOfFoodDrugAndMassRetailStoresDistributedIn
Namespace Prefix: | prph_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number Of Inhibitors + References No definition available. + Details
Name: | prph_NumberOfInhibitors
Namespace Prefix: | prph_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number Of Lab Entities Filed For Chapter 11 Reorganization + References No definition available. + Details
Name: | prph_NumberOfLabEntitiesFiledForChapter11Reorganization
Namespace Prefix: | prph_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number Of Licensed Compounds + References No definition available. + Details
Name: | prph_NumberOfLicensedCompounds
Namespace Prefix: | prph_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 + Details
Name: | us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=prph_DNAExpandMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=prph_EquivirMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=prph_BESmartLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |